| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Inotrem Control innate immunity Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock. Founded in 2013, with offices in Paris and a technology center in Nancy (France), the company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide, with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases. Tags: FrenchTech120 Type: | 7 | 6 | 1 | 34 |
 | IntelliDigest Empowering Global Food Sustainability. IntelliDigest is a purpose driven company that is empowering global food sustainability through technology innovation and capacity building. Our cutting-edge research and innovative technology solutions are enabling businesses in the food system from farm to fork to become more sustainable; improving the way we grow food, distribute and consume food while eliminating edible food waste and upcycling inedible food waste back into the food system in the most efficient way to grow more nutritious food locally. Through knowledge exchange and capacity building, we are providing awareness to stakeholders in the food system and policy makers on … Type: | 2 | 0 | 0 | 22 |
 | Cumulus Neuroscience Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience. Type: | 5 | 2 | 0 | 47 |
 | iLoF Using AI and Photonics to enable a new era of personalized, precision medicine. iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported … Type: | 18 | 0 | 15 | 39 |
 | CariGenetics We are a genetics company transforming the way pharmaceutical companies develop drugs to include non-european data. Biomedical and biodiversity research driving transformation in healthcare and environmental conservation through genome Biomedical, Biodiversity, Genome Research, Healthcare, Environment, Conservation, Caribbean, and Biotech Type: | 2 | 0 | 1 | 13 |
 | AgStart Accelerating Innovation in Ag|Food|Health When it comes to getting your ag/food/health innovation from proof of concept to commercialization, many startups are overwhelmed by the logistics. AgStart helps ag/food/health startups by simplifying the process and provides access to a wealth of resources so they can get their world-changing technologies funded and out into the world. Situated in the heart of Ag Innovation, AgStart knows the logistics of creating profitable ag/food/health startups and has the industry connections and know-how to de-risk the process so you can get to work faster and spend less money. Since 2021 we have helped 12 resident companies … Type: | 1 | 0 | 1 | 2 |
 | Solinatra The truly sustainable alternative to single use plastic | Biodegradable, compostable, 100% natural and plant based 🌍🌿 Solinatra is the truly sustainable solution to single use plastics. Innovative biomaterials that are 100% natural and plant based, with all the benefits of plastic and none of the drawbacks. Fully biodegradable and compostable in all situations, Solinatra doesn’t leave behind any microplastics. Blends of Solinatra are available to suit a wide range of applications, with food and non-food contact approved materials suitable for manufacturing in existing production lines. biomaterials, compostable materials, biodegradable materials , sustainability , and circular economy Type: | 2 | 0 | 1 | 19 |
 | Venomtech Ltd Our goal at Venomtech is to lead the way towards an era where venom-based research tools are routinely used as sources Venomtech targeted arrays provide a unique opportunity to identify novel screening tools and discover novel therapeutics. Animal venoms are a complex mix of peptides, small molecules and proteins that bind, activate, inhibit or otherwise modulate molecular targets such as ion channels, GPCRs and kinases. Screening crude venoms to identify bioactive components is made extremely difficult by a large number of potentially conflicting activities (e.g. cytotoxins masking pharmacology) and de-convolution challenges. In the past, these challenges have hampered many of … Type: | 1 | 0 | 1 | 8 |
 | BioSTL Driving St. Louis Innovation through startups | capital | people | place | policy | global connectedness Since 2001, St. Louis nonprofit BioSTL has laid the foundation for the region's innovation economy with a comprehensive set of transformational programs that advance St. Louis’ leadership in solving important world challenges in agriculture, medicine, healthcare, and other technology areas. BioSTL has introduced nationally-acclaimed initiatives in startup creation and investment (BioGenerator), strategic business attraction (GlobalSTL), physical environment (including the Cortex Innovation District and BioGenerator Labs), entrepreneur support, seed and venture capital, a diverse and inclusive workforce, and public policy. Vision: St. Louis will … Type: | 6 | 4 | 2 | 31 |
 |  Seelos Therapeutics, Inc. A clinical-stage biopharmaceutical company focused on central nervous system disorders and rare diseases. Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL". Rare Diseases, Parkinson's Disease, Sanfilippo Syndrome, Suicidality, Depression, PTSD, MDD, CNS Disorders, … Type: | 2 | 0 | 1 | 22 |
 | BioNeed - Conseils stratégique et appui opérationnel Secteur Biotechnologie-santé [Automatic translation follows] Your teammate in innovation marketing, business development and activity management www.bioneed.fr Operational support for managers of biotechnology/health companies. BioNeed offers consulting services, tools and field support to deploy your business project, boost your performance and strengthen your marketing & commercial. The services are mainly focused on innovation marketing, commercial strategy and activity management. For who? BioNeed is mainly aimed at SMEs at different stages of their development: pre-creation, first development, growth, etc.). How? Operational support in your business and interventions adapted to your needs and your stage of development. One-off mission or on the principle of shared … Type: | 3 | 0 | 3 | 1 |
 | Bio4Comp – Parallel Network-Based Biocomputation Enabling future biocomputers Biocomputers are expected to be the future of computing, potentially being more economical and energy efficient. We are one of the international initiatives working to make it a reality. The idea behind Bio4Comp, an EU-funded research project, is that biomolecular machines, each only a few billionth of a meter (nanometers) in size, can solve problems by moving through a nanofabricated network of channels designed to represent a mathematical algorithm. We call our approach "network-based biocomputation". Whenever the biomolecules reach a junction in the network, they either add a number to the sum they are calculating or leave … Type: | 0 | 0 | 0 | 3 |
 | PHAXIAM Therapeutics Creating a global leader in extended phage therapies PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris … Type: | 11 | 3 | 6 | 90 |
 | Innate Pharma Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical … Type: | 18 | 7 | 11 | 202 |
 | MindMaze Accelerating humanity’s ability to recover, learn and adapt through advanced neuroscience and digital therapeutics. MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate … Type: | 6 | 1 | 2 | 181 |
 | BIOSENIC S.A. New solutions for autoimmune, inflammatory and bone diseases. BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases and organ repair. Cell therapy, Bone and joint tissue regeneration, Osteo-Articular Diseases, autoimmunity, immunity, autoimmune disease, and arsenic Type: | 6 | 3 | 2 | 26 |
 | BIOVAL Clúster BIO Comunidad Valenciana BIOVAL, Valencian Bioregion, is a private association born as a business oriented initiative to help develop the biotechnology sector of the Valencian Region as an impulse in economic and social development. Since the end of last year, we have been included in the Innovative Business Group (Agrupación Empresarial Innovadora or AEI in Spanish), a title given by the Spanish Ministry of Industry, Tourism and Commerce. After establishing BIOVAL as the reference for the biotechnology sector in the Valencian Region, we put together a strategic plan for the development of the area as a Bioregion. This is the regional development model … Type: | 12 | 1 | 9 | 15 |
 |  Perpetual Biotechnologies Founded in 2015, as a renewable clean technology company, our mission is to develop sustainable algae derived products and ideas that will embrace the nature and help humanity. Algae, Nutraceuticals, Cosmetics, Pharmaceuticals, and Cleantech Type: | 0 | 0 | 0 | 2 |
 | LONO Côte d'Ivoire Transformez vos sous-produits en revenus supplémentaires LONO is a biotechnology company in Côte d'Ivoire, converting organic waste into electricity and fertilizer. Agriculture, Biotechnology, and Sustainability Type: | 2 | 1 | 2 | 15 |
 | PB&B Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, … Type: | 0 | 0 | 0 | 4 |
 | MIP Discovery nanoMIPs - synthetic antibodies with robust characteristics and secure supply Our proprietary technology includes a novel method to make nanoMIPs which circumvents the drawbacks of traditional MIP manufacturing methods. NanoMIPS are, as the name suggests, nanostructured polymer particles typically containing a single binding site for their target. They can also be fused to solid substrates, such as sensor surfaces, if required. The robust nature of MIPs and nanoMIPs make them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing. As they are synthetic polymers, MIPs can withstand harsh chemical environments such as extremes … Type: | 0 | 0 | 0 | 32 |
 | SOPHiA GENETICS Democratizing Data-Driven Medicine, Together! SOPHiA GENETICS is the creator of SOPHiA DDMTM, a cloud-based platform capable of analyzing data and generating insights from complex multimodal data sets and different modalities. The SOPHiA DDMTM Platform enables healthcare institutions to get quick, robust insights from their data. We apply our technology to areas such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support research and drug development efforts. SOPHiA GENETICS' data-sharing methodology also helps researchers and healthcare professionals work together as a community by sharing and leveraging patterns identified via artificial intelligence and machine learning. Our … Type: | 23 | 10 | 11 | 484 |
 | SwissDeCode Real-time food quality, authentication and compliance for farmers, food manufacturers and food authorities. SwissDeCode helps farmers and food manufacturers to grow and produce high quality products by offering a variety of rapid, on-site DNA testing solutions. We help brands launch new premium products faster and companies to transition to more sustainable value chain practices. Get in touch to discuss your testing needs. Food Authentication, Supply Chain Traceability, DNA Testing, Sustainable Operations, Food Compliance, Right First Time, Undeclared ingredients, Antimicrobial Resistance, Product Recalls, Process improvement, Food DNA, Food Defense, Supplier specifications, Evidence of origin, A2 milk, and Cocoa Swollen Shoot Virus Type: | 7 | 3 | 4 | 10 |
 |  Vicept Therapeutics, Inc Start-up Dermatology Company. Type: | 11 | 1 | 0 | 1 |
 | VectivBio AG Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and … Type: | 2 | 0 | 1 | 57 |
 | Livinguard Livinguard’s patented hygiene technology platform uniquely turns any textile into a permanent self-disinfectant. xxxxxxxx Type: | 3 | 0 | 2 | 37 |
 | Valence Labs Redefining scientific discovery to radically improve lives Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery. Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) in May 2023, Valence Labs continues as a semi-autonomous AI research engine within Recursion aiming to advance the frontier of deep learning in drug discovery. Valence Labs operates with the unique combination of the intellectual freedom of academia but the resources and stability of industry. Valence Labs is headquartered in … Type: | 9 | 1 | 7 | 38 |
 | ALGAIA Your Natural Partner Algaia is a company developing, producing and commercializing Natural Extracts, mostly made out of seaweed. Algaia offers a unique range of Natural and Sustainable products & solutions to the Food, Nutraceutical, Personal Care, Medical Device and Pharmaceutical industries and for Agriculture. Algaia Services is a division of Algaia offering R&D analytical services on micro-algae and macro-algae biomass. To learn more, please visit us at www.algaia.com Seaweeds, Natural Extracts, Sustainable processes, Laboratory analysis, Bioactivities, and Alginate manufacture Type: | 18 | 7 | 13 | 56 |
 | HCS Pharma Biotechnology company focused on in vitro R&D with exclusive and innovative 3D cellular models in BIOMIMESYS® ECM HCS Pharma is a biotechnology company focused on in vitro R&D, specializing in high content (HCA) and high throughput (HCS) cell imaging screening. HCS Pharma sells products based on BIOMIMESYS® technology, and develops its own 3D cellular models in its proprietary BIOMIMESYS® extracellular matrix. BIOMIMESYS® 3D culture technology faithfully reproduces the natural microenvironment of cells in 3D, to ensure more predictive results from in vitro studies, to reduce the time and cost of R&D, and animal testing in pharmaceutical, nutraceutical and cosmetic companies. … Type: | 10 | 3 | 7 | 20 |
 | BIOMEDICAL TISSUES Biomedical Tissues is specialised in the research and development of implantable medical devices for the regeneration of human tissue. We have invented a novel way to produce microfibers of synthetic biodegradable polymers which can be used as tissue regenerative guides. These devices mimic the structure of collagen fibers offering a 3D environment for cell colonization and proliferation for tissue healing. Our first product to market is Tisseos, a new resorbable synthetic membrane for dental implantology and periodontology. Biomedical Tissues also offers implantable biomaterial and medical device testing and evaluation services for cardiovascular, dental and orthopaedic implants, osteoinductive materials, tissue engineering … Type: | 0 | 0 | 0 | 2 |
 | Atoxigen ATOXIGEN is your partner in early R&D. We offer a variety of standardized or customized assays based on the latest innovations in the fields of cellular biology, molecular biology and genomics. Innovative predictive efficacy assays on reconstructed epidermis or primary cell lines from human explants (proteasome, autophagy, detoxification, anti-ageing...); in vitro genotoxicity testing (micronucleus and chromosome aberration tests); endocrine disruptor screening; customized services. Biotechnologies, Testing & Research, Evaluation toxicologique, and Assurance qualité Type: | 1 | 0 | 1 | 3 |
 | Abbelight [Automatic translation follows] From Microscopy to Nanoscopy _ Scalable bioimaging solutions and multiple expertise to speed-up your imaging projects Founded in 2016, Abbelight is a fast-growing company specialized in imaging solutions focusing on microscopy and unique single molecule detection (super-resolution). The portfolio integrates a constantly evolving knowhow on chemistry, optics and computer science to offer a complete solution, from sample preparation to data management, including an optimal bio-imaging platform that can be adapted to all researchers', biotech labs' and medical facilities' needs. Abbelight is a French company developed by four passionate researchers who aim to help improve human health in … Type: | 8 | 4 | 6 | 47 |
 | Dynacure Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. Dynacure is headquartered in … Type: | 6 | 5 | 2 | 11 |
 | Advanced BioDesign Overcoming Tumor Drug Resistance Founded in 2010, Advanced BioDesign is a clinical stage company developing a highly promising therapy for cancer with high unmet medical needs. Advanced Biodesign has developed a therapeutic approach based on a selective inhibition of ALDH enzymes. Advanced Biodesign project consist in the development of small-molecule that will selectively inhibit specific ALDH enzyme. By targeting this family of enzyme, will block specifically the intracellular mechanism of detoxification that cancerous cells have developed in order to escape form the programmed cell death called apoptosis. Oncology Type: | 4 | 1 | 3 | 22 |
 | INOVACTIS [Automatic translation follows] A versatile immunotherapy for personalized cancer medicine Inovactis is developing an innovative treatment against cancer on the border between several ongoing revolutions: individualized medicine, immunotherapy and synthetic biology. immunotherapy and personalized medicine Type: | 0 | 0 | 0 | 1 |
 | NOVAPTECH The Aptamer Expert Company Novaptech develops aptamer-based tools in the frame of technology transfer and innovation projects. Novaptech’s expertise is focused on the identification and the characterization of aptamers for biotechnological development of analytical and diagnostic aptamer projects. Novaptech develops collaborative projects or service agreements with academic laboratories and R&D department of companies. Novaptech works in close association with Dr. Toulmé ’s team, an academic laboratory (Inserm U1212, Bordeaux) which has more than 26 years of experience in aptamer selection. Research and Development and Therapeutics and Diagnostics Type: | 1 | 1 | 0 | 11 |
 | Abivax Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. Abivax also plans to initiate a Phase 2a clinical trial of obefazimod in patients with Crohn’s disease. Obefazimod is an investigational, orally administered, once-daily therapy, which we believe has the potential to be a differentiated treatment option for inflammatory bowel diseases. It is the first and only molecule … Type: | 8 | 5 | 4 | 78 |
 | Scienta Lab AI-powered Precision Immunology Scienta Lab is a deeptech company developing a unique and proprietary artificial intelligence technology to transform the drug discovery and development process in immunology and inflammation. Artificial Intelligence, Clinical Trials, and Immunology Type: | 10 | 4 | 8 | 9 |
 | ImCheck Therapeutics Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune … Tags: FrenchTech120 FrenchTech2030 Type: | 28 | 13 | 18 | 51 |
 | Alkion BioInnovations Disruptive solutions to produce high-value plant-based ingredients Alkion BioInnovations is a pionnier & leader in plant tissue propagation and bioengineering technologies. We have developed and patented a bioproduction platform to obtain high value ingredients (APIs, complex extracts and recombinant proteins) from plant biomass for pharmaceutical & agri-food markets on global and impactful projects. Through a carbon-neutral approach and using a minimum of resources in optimised bioreactors, our method of production is sustainable, ultra-scalable and cost-efficient. With our European partners, we develop AI robots to build the world's first industrial in-vitro bioproduction platform, that aims to be flexible and versatile. Our … Type: | 4 | 1 | 4 | 12 |
 | Valneva Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines. … Type: | 22 | 9 | 5 | 623 |
 | BILHI Genetics The genetic platform to EXPLORE, PREDICT and CURE fibrotic diseases We are a team of GENOMIC EXPLORERS dedicated to cure fibrosis. We work hand in hand with populations under strong natural selection pressure (e.g. Amerindians from Brazil, Allurs, Bantous from Uganda, Hans from Wuhan...) to identify GENETIC VARIANTS of susceptibility or resistance to fibrotic diseases. To explore the mechanisms of fibrosis in new depth, we rely on a unique genomic strategy based on medical genetic expertise in fibrosis, local networks of fields experts and state-of-the-art AI. In cooperation with local institutions & KOLs, our experts have analyzed tens of thousands … Type: | 1 | 1 | 1 | 7 |
 | GreenTropism AI for diagnostics and Industry 4.0 GreenTropism is a French startup specialized in Artificial Intelligence (AI) and spectrometry. Greentropism set up its activity in Rouen in November 2021 to perfect the development of a unique and very innovative, ultra-fast (less than 3 minutes) solution for pathogens detection including those of Covid-19, again based on spectrometry + Artificial Intelligence. Since 2014, the company has built up its know-how by developing data analysis algorithms dedicated to applications for control/sorting of materials, contamination control or various diagnostics. The applications of the Kaïssa Artificial Intelligence platform are of interest to many markets, food, cosmetics, … Type: | 9 | 2 | 7 | 8 |
 | MYRIADE Reveal the invisible Myriade is a French company created in 2017 that develops an innovative nanoscale imaging technology. Based on the works of the Langevin Institute, a French academic laboratory specialized in optical and ultrasonic technologies for life sciences, the technology Videodrop relies on a single-arm interferometric technique. It makes it possible to visualize without labeling living nanoparticles such as viruses, phages, or extracellular vesicles. The process was developed by Professor Claude Boccara at the request of the Professor Martine Boccara, specialist in virology, who was looking for a quick method to list viruses present in seawater samples collected during … | 1 | 1 | 0 | 25 |
 | GAIAGO We believe that Mankind thrives when Soils thrive. We aim to become world leader in Soils revitalization 🚀#hiring 🚀 GAIAGO is an Agtech company based in the region of St Malo, France. Only healthy Soils allow abundant and quality food production. We produce a new generation of Soil improvements tools, effective for all agricultures. We contribute to the farmer’s mission: cultivate and transmit a healthy and fertile Soil AgTech, Biotechnology, Agronomy, and Soil Tags: FrenchTech2030 Type: | 22 | 8 | 16 | 65 |
 | Alvéole Bioengineering unleashed! Tools for better cell sample preparation: better cell models for cell biology and microscopy. Created from work carried out by three research experts, Alvéole’s goal is to make the control of living cells the future of cell biology. A company specialized in devices for controlling the cellular microenvironment, Alvéole presents its first device PRIMO. Alvéole was founded in 2010 by three researchers from CNRS* in collaboration with Quattrocento, a “creator of young innovative companies” in the life sciences field that allows academic researchers to transform their inventions into commercial products. Vincent Studer (a specialist in bio-engineering), Maxime Dahan … Type: | 6 | 0 | 5 | 14 |
 | ManRos Therapeutics From Sea to Pharmacy ManRos Therapeutics is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors for the treatment of cystic fibrosis. ManRos was founded in 2007 and is led by Dr Laurent MEIJER, Chairman and CSO, former distinguished Director of Research at the CNRS, and Dr Philippe de Lavenne, CEO, former Vice-President at Actelion Pharmaceuticals. For 40 years, Dr Meijer dedicated his research to the study of protein kinases and their inhibitors, mostly at the CNRS. Drug Development, Cystic Fibrosis, and Biotechnology Type: | 1 | 1 | 0 | 5 |
 | Thabor Therapeutics Develops innovative treatments for mucosal inflammatory diseases Thabor's website Type: | 0 | 0 | 0 | 9 |
 | Roca Therapeutics A united team creating an innovative therapy to give a new life / vision to patients First In Class Drugs against diseases favored by hyper-vascularization and immuno-suppressive inflammation Cancer treatment, Eye disease, Angiogenesis, Inflammation, Drug development, and Personalized therapy Type: | 7 | 3 | 0 | 6 |
 | Meccellis Biotech French manufacturer of biologic implants Meccellis Biotech is a company expert in Tissue and Cell Engineering with a diversified offer for multiple surgical specialties. After 7 years of marketing, Meccellis Biotech is now present in 25 countries. The passion and professionalism of its teams have made of Meccellis Biotech, a reference company for the manufacturing of biomaterials. For any further information you may need regarding our range of biologic implants, please feel free to contact us: contact@meccellis.com - Phone number: +33 (0) 5 17 81 07 63 - THE MECCELLIS BIOTECH TEAM Breast reconstruction: CELLIS Breast, General surgery: CELLIS, and … Type: | 5 | 1 | 2 | 10 |
 | WhiteLab Genomics AI/ML for Genomic Therapies We are specialised in AI solutions for advanced therapies such as gene and cell therapies. Tags: FrenchTech2030 Type: | 38 | 15 | 27 | 38 |
 | StarkAge Therapeutics Immunotherapy against senescence StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs. Type: | 1 | 1 | 0 | 10 |
 | Ciloa SAS Inspired by Exosomes CILOA’S CUSTOMIZED EXOSOMES FOR INNOVATIVE THERAPEUTICS Ciloa is the most experienced exosome-based R&D Company dedicated to the development of new high-potential bio-drugs. By overcoming undruggable targets, Ciloa supports your projects to create new therapeutic and new preventive solutions. Ciloa customizes in vivo exosomes to contain i) fully native membrane protein complexes (GPCRs, Kinase Receptors, Ion Channels, Viral Antigens, Transporters...) embedded in their membrane and ii) chosen cargo proteins inside their cytosol. Natural properties of exosomes combined with Ciloa in vivo disruptive technology allow to develop: - VIRUS-FREE candidate THERAPEUTIC VECTORS able to deliver specifically chosen cargos to … Type: | 3 | 3 | 0 | 9 |
 | POLYGON Therapeutics Innovation. Applied. Bringing life to life. POLYGON Therapeutics aims to address unmet therapeutic needs through innovative breakthrough approaches. Within its first therapeutic development program EMOTION, POLYGON aspires to transform cardiovascular diseases care. Type: | 12 | 5 | 10 | 9 |
 | Polaris Taking Omega-3 to the next level POLARIS, expert in innovative nutritional lipids, offers a range of health ingredients and high-valued custom manufacturing activity. POLARIS is specialized in production and formulation of Polyunsaturated Fatty Acids especially Omega-3 from marine and algal origin under the brand Omegavie. Nutritional lipids, Biotechnologies, Lipochemistry, and Green chemistry Type: | 2 | 2 | 0 | 43 |
 | Plantik Biosciences Building resilient crops through next-generation plant engineering technologies. Resilient plants are at the heart of our fight against climate change. Plantik develops technologies to create resilient plants that survive today’s challenges, for a better tomorrow. Type: | 3 | 1 | 3 | 7 |
 | CarbonWorks CarbonWorks industrialise la photosynthèse microalgale CarbonWorks develops an industrial platform for CO2 capture by microalgal photosynthesis - CO2 is recovered into natural raw materials on a large scale 5 years R&D, breakthrough innovations, CarbonWorks benefits from the cutting-edge expertise of Suez and Fermentalg. #CCU #microalgaes CCU - Carbon Capture and Utilization, Natural raw materials, and Microalgae Type: | 8 | 3 | 5 | 18 |
 | Ermium Therapeutics Controlling auto-immune diseases Ermium Therapeutics is a discovery stage Biotechnology company developping innovative therapies for auto-immune diseases Type: | 2 | 2 | 0 | 9 |
 | Jalon Therapeutics Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Our mission is to develop medicines that will transform the lives of people fighting cancer. For that purpose, we leverage our deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. This mechanism, defined as “non-oncogene addiction” (NOA), offers potential novel, safer and more effective therapeutic strategies. Jalon Therapeutics is rooted in pioneering fundamental research and clinical investigations from INSERM laboratories … Type: | 0 | 0 | 0 | 5 |
 | Brenus Pharma Tumor-antigen focused immunotherapies anticipating tumor plasticity, resistance to treatments and relapses ✔️🟣 Brenus Pharma, french private start-up in biotechnology based in Lyon, develops a platform technology to deliver first-in-class tumor-antigen focused immunotherapy. The STC (Stimulated Tumor Cells) Technology allogeneic platform deliver STC drug product, in 3 major steps: 🟣 Cell Selection to mimic tumor heterogeneity & resistance capacities of the selected indication. 🟣 In vitro induction and overexpression of resistances marker by stimulation with Standard of care and Rx. • 100+ cancer related surface proteins over expressed • Cross-matching human tumoral biopsy databases • Covering 3 categories of targets (Tumor … Type: | 17 | 6 | 9 | 14 |
 | LinKinVax LinKinVax aims at creating a universal, safe, enduring, vaccines platform against multiple pathogens. We are a clinical stage Biotech Spin-off of the Vaccine Research Institute in France with a unique "DC targeting" platform covering infectious desaeses and oncology. Type: | 10 | 0 | 10 | 13 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. Type: | 9 | 3 | 6 | 64 |
 | BiPER Therapeutics First in class small molecules pushing cancer cells to burn out BiPER Therapeutics is developing a first-in-class pipeline of small molecules targeting the global metabolism of cancer. The company’s lead compound, BPR001, is a first-in-class small molecule therapeutic targeting BiP, an oncogenic protein shown to have a critical role in cancer through the modulation of the endoplasmic reticulum stress. Type: | 10 | 6 | 9 | 7 |
 | xRapid Group Pushing the boundaries of Artificial Intelligence in diagnostics Environmental Services - Biotechnologie Founded in 2015 by Jean Viry-Babel and Prof. David Mendels, xRapid Group was created with the hope of applying the evolving technologies of artificial intelligence (AI) and computer vision to previously unexplored fields with the hopes of improving the lives of people the world over. The first application of Prof. Mendels knowledge was to tackle the issue of diagnosing malaria in remote areas where the demand for skilled analysts exceeded the supply of resources, both human and monetary. It was during the research and development of this application … Type: | 7 | 3 | 5 | 1 |
 | Immusmol Immusmol develops small molecule antibodies for research, diagnostics and therapy. Combining 25 years of experience in antigen design, we offer to target low molecular weight molecules, which are not usually addressed by antibodies, such as amino acid metabolites, lipids, saccharids, toxins, pesticide residues, small molecule drugs, ... Compatible with existing antibody-based technologies, our small molecule antibodies can serve for: > VISUALIZATION: Small molecule antibodies currently represent the only applicable technology for the visualization of small molecules in cells and tissues by IF or IHC. > QUANTIFICATION: Combined with ELISA/EIA technologies, small molecule antibodies enable rapid and robust detection of small … Type: | 1 | 1 | 0 | 11 |
 | INOVOTION Which molecule will stand out INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies. Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage. This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities. This next generation of in vivo efficacy … Type: | 9 | 5 | 5 | 21 |
 | Ecrins Therapeutics Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production … Type: | 2 | 0 | 2 | 1 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 16 | 8 | 11 | 10 |
 | Woodlight [Automatic translation follows] Let’s cultivate the light of tomorrow! Since its founding in January 2016, Woodlight has been a research and development startup for new biotechnologies. Its objective is to make cities greener by responding to their problems of pollution, lack of greenery and high energy consumption. To meet the growing needs for sustainable lighting and energy saving in cities, Woodlight is proposing to develop a process to make plants bioluminescent. These plants can be used as mood lamps for interior decoration. We can then imagine an ivy, a ficus or even a luminescent orchid. Beyond these uses, these plants … Type: | 29 | 4 | 27 | 4 |
 | ENZYNOV [Automatic translation follows] The power of enzymes (white biotechnology) for detergency ENZYNOV is a young international company invested in biotechnological innovation of enzymatic eco-solutions and their applications for professionals. Economical, ecological and efficient, our eco-solutions are risk-free for your employees and our environment. They are applicable to all sectors of activity. We support our customers in France and the United States in optimizing their natural cleaning processes through easier surface maintenance using our biocatalysts in the sectors of industrial production, ERP, the food industry, the oil industry... Contact us to benefit from a personalized service. contact@enzynov.fr The Enzynov Team Maintenance, … Type: | 2 | 0 | 2 | 4 |
 | OSE Immunotherapeutics Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients OSE Immunotherapeutics is an integrated biotech company focused on developing first-in-class assets targeting cancer and inflammatory diseases. A current well-balanced first-in-class clinical pipeline including: • Tedopi® (T-cell specific immunotherapy): Company’s most advanced product; positive results for Ph 3 in NSCLC in secondary resistance after CKI failure. Other sponsored combo Ph 2 trials in solid tumors ongoing. • OSE-279 (anti-PD1) advanced preclinical stage • OSE-127 (humanized mAb antagonist of IL-7R); ongoing Ph 2 in Ulcerative Colitis; ongoing preclinical research in leukemia • VEL-101/FR104 (anti-CD28 mAb) developed in partnership with Veloxis in transplantation; ongoing … Type: | 9 | 6 | 2 | 1 |
 | AnyGenes® Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by … Type: | 0 | 0 | 0 | 7 |
 | ANAQUANT Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary … Type: | 2 | 1 | 2 | 10 |
 | Simedys [Automatic translation follows] Never the first time on the patient, In the service of surgeon training Simedys revolutionizes the teaching of surgical gestures with its simulation technology offering an unprecedented level of realism and validation of achievements through the development of educational scenarios designed by the surgical community. Simedys P4P by SIMEDYS®, makes surgical training possible and unique through its simulation system based on donated bodies. Resulting from a collaboration between engineers and surgeons, this technology fills the holes in the practical and realistic training for surgeons. , a necessity emanating both from market demand for organ harvesters and from … | 1 | 1 | 0 | 4 |
 | kyron.bio Next generation bioproduction platform Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical … Type: | 10 | 3 | 8 | 5 |
 | CLEAN BIOLOGICS Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance Type: | 13 | 7 | 11 | 11 |
 | IMODI Cancer Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer Type: | 1 | 0 | 0 | N/A |
 | EXCILONE [Automatic translation follows] The future is now A company specializing in Imaging and Micro and Nanogenomics, Excilone offers solutions that meet the needs of private pharmaceutical and cosmetic research companies, academic or anatomical pathology laboratories, with a unique business model. As both a solutions seller and a service provider, we offer a dual approach for the analysis of your samples: - by image, with the entire histological process, from sample preparation to image analysis - by molecular content, with a combined NGS/qPCR offer in oncology. System developers, our range of PathScan® scanners dedicated to FISH and high-resolution scanning, the TMA … | 0 | 0 | 0 | 14 |
 | LXRepair 2013-2023 In a context where the rate of cancer treatment failure is still unacceptably high, our mission is to provide decision aids to oncologists. We believe that profiling is key to predicting treatment toxicity to patients and effectiveness on tumors. Over a decade of research by the French Atomic Energy Commission (CEA) on the impact of radiations on DNA has resulted in a deep understanding of the essential DNA repair mechanisms. More recently, a set of innovative biomarkers was developed that provides a complete functional signature of these mechanisms, the premise to powerful tools for personalized treatment of cancer. http://www.lxrepair.com … Type: | 2 | 1 | 1 | 3 |
 | Vidium Solutions Data analysis and in silico modelization solutions for genetic research and personalized medicine Expert in systems biology, VIDIUM brings data analysis and in silico modelization solutions for genetic research. We unlock the power of single-cell analysis to characterize and master the complexity of cell fate dynamics: "As Google did for urban networks, we built our navigation map in cellular genetic networks!" Guided by knowledge-driven approaches, we create highly representative digital twins from single-cell data, to make accurate predictions. These in silico avatars of genetic networks allows us to "find our way" through the billions of possible interactions between our 20,000 … Type: | 5 | 0 | 4 | 13 |
 | AXO Science Complete screening of the rape scene: STK Lab, STK Spray & STK Skin AXO Science is a French leading biotechnology company focused on innovation in the field of molecular biology and forensic science. In collaboration with the French Institute ICBMS and the French Police Forensic Dpt (INPS), AXO Science is the pioneer in the manufacturing of semen screening tests. Indeed, we developed two forensic products to detect sperm stains on crime scene (e.g sexual assaults) and laboratory. ISO 90001, ISO 13485 and ISO 18385 certified, AXO Science presents the highest quality standard and its bioanalytical laboratory comprises the most recent … | 6 | 1 | 1 | 8 |
 | AUROBAC THERAPEUTICS Developing the next generation of precision medicines to fight antimicrobial resistance (AMR) and infectious diseases. AUROBAC THERAPEUTICS is a biopharmaceutical company created in 2022 by three highly renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to develop the next generation of precision medicines addressing the medical needs associated with the development of antimicrobial resistance and infectious diseases. The company is building a pipeline of drug candidates for hospitalized patients, associated with rapid diagnostics to identify pathogens and their resistance mechanisms. This 40 million euros-funded joint-venture plans to cover the entire value chain of projects from R&D, including clinical … Type: | 3 | 1 | 2 | 16 |
 | MEXBRAIN [Automatic translation follows] Therapeutic dialysis devices for metal extraction MexBrain develops medical devices capable of specifically, quickly and controlledly extracting metals. MexBrain has designed an ultrachelating platform: fluids capable of extracting metals associated with dialysis systems. These devices are specific to the targeted metals and have an adjustable extraction capacity. No medication or product circulates directly in the body, limiting side effects. Nanotechnologies, Dialysis, Metals, and Chelation Type: | 9 | 2 | 1 | 13 |
 | LabSkin Creations Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue Type: | 7 | 6 | 1 | 10 |
 | Cellenion Experts in single cell isolation technology for sequencing and cell line development applications. Cellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of single-cell isolation and bioprinting : Ability to manipulate single-cell has long been a challenge for the scientific community due to their micrometric size and delicate nature. Cellenion has developed and patented CellenONE, a breakthrough single cell isolation and dispensing technology. CellenONE provides outstanding single cell precision, high throughput, and unmatched recovery. Bioprinting is the process of generating spatially-controlled cell patterns using 3D printing technologies. Cellenion will aim toward both miniaturization and automation … Type: | 3 | 1 | 2 | 28 |
 | HEPHAISTOS-Pharma [Automatic translation follows] Developing the weapons that we need to defeat cancer. HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies to revolutionize cancer treatments by increasing the effectiveness of monoclonal antibodies and enabling the treatment of incurable tumors. Oncology, immunotherapy, and cancer | 12 | 6 | 5 | 9 |
 | BIOMNIGENE Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - … Type: | 2 | 2 | 2 | 6 |
 | NETRI INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology Type: | 28 | 9 | 23 | 39 |
 | KUSTE BIOPHARMA KUSTE is a Clinical Stage Biopharma Company founded by seasoned entrepreneurs in Life Science KUSTE is a Clinical Stage Biopharma Company founded by seasoned entrepreneurs in Life Science with the aim of tackling major chronic inflammatory diseases | 1 | 1 | 0 | 4 |
 | SpyBiotech Utilizing unique protein superglue technology to develop vaccines against infectious disease and cancer worldwide SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year. Vaccine Development Type: | 2 | 1 | 1 | 21 |
 | Discovery Park A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, … Type: | 7 | 0 | 7 | 59 |
 | Qkine High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and cellular agriculture Qkine manufactures high-quality and novel growth factors, supporting scientists in developing and scaling stem cell, organoid, cellular agriculture and regenerative medicine applications. We are also developing new growth factor technologies to enable emerging fields such as cultured meat and 3D cell culture. All Qkine high purity animal-free growth factor proteins are manufactured at our facility in Cambridge, UK . Extensive quality testing is conducted on every lot to guarantee reproducibility. Based on proprietary technology developed in the laboratory of Dr Marko Hyvönen, senior … Type: | 6 | 3 | 6 | 40 |
 | Prokarium LIVING CURES Prokarium is pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects. Biotechnology, Vaccines, Oral delivery, Immunology, Synthetic Biology, Oncology, Microbial Immunotherapy, and Immunotherapy Type: | 4 | 0 | 1 | 21 |
 | BioKind We create sustainable protein ingredient for animal feed. Currently in stealth mode. BioKind protein is a natural, sustainable and traceable feed ingredient for aquaculture, livestock and pets. Produced via a natural fermentation, it is non-GMO, price competitive with existing sources of protein and produced to the highest quality standards. Biotechnology Type: | 2 | 0 | 1 | 1 |
 | Deep Branch We use clean and renewable carbon and energy sources to create ingredients for a more sustainable food system. Deep Branch uses clean and renewable carbon and energy to create ingredients for a more sustainable food system. With a customer-focused research and development pipeline, it can quickly deliver high-quality, next-generation bio-based products to meet society’s demand for food and feed sustainably. By collaborating with local providers of strategic raw materials, Deep Branch can identify the best sites that offer sustainable input supply while helping develop the local economy. The company’s proprietary (R)evolveTM gas fermentation platform also uses sustainable and scalable feedstocks, … Type: | 16 | 1 | 12 | 28 |
 | Jellagen A Revolutionary Platform for Regenerative Medicine Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications. Medical Grade Collagen, Native Collagen, Cell Culture Reagents, Wound Healing, Hydrogels, Non Mammalian Collagen, Collagen, Reagents, Marine Biotechnology, regenerative medicine, 3dscaffolds, collagencoatedplates, and 3dsponges Type: | 0 | 0 | 0 | 14 |
 | MeiraGTx Engineering Hope MeiraGTx is a gene therapy company with end-to-end capabilities in gene therapy discovery, development and GMP manufacturing. The company currently has 6 clinical programs, including one in a pivotal study. In addition, MeiraGTx has two wholly owned GMP manufacturing facilities, a leading proprietary manufacturing platform process, large scale GMP plasmid production as well as in-house fill and finish and QC for stability and release. This infrastructure supports multiple clinical programs from IND through commercialization. MeiraGTx has also built industry-leading vectorology capabilities including optimization of all viral vector elements, with multiple discovery platforms from de-novo construction thorough AI driven … Type: | 3 | 0 | 2 | 392 |
 | Scindo Scindo is developing novel biocatalysts to enable sustainable ingredients from natural or up-cycled feedstocks. More sustainable products, for everyday use Carbon chains are the backbones in most modern products, extracted from crude oil and converted into anything from materials to ingredients. Scindo is working towards a circular future, where your favourite products are sustainably manufactured from renewable or recycled feedstocks. We are developing cutting-edge enzyme systems to address two global challenges: the reliance on crude oil, and the global plastic waste crisis. Type: | 1 | 0 | 1 | 7 |
 | Vitaccess Helping you to generate patient-centered data and insights. We are a patient-centered research organization. At Vitaccess, we redefine the landscape of real-world evidence (RWE) generation through our groundbreaking Vitaccess RealTM platform. Powering your studies, our platform and our expert team enable you to gain deeper and faster insights into the impact of diseases and treatments in the real world. We are: Specialists in Real-World Primary Data Collection: We design and run studies collecting data directly from patients, caregivers, and clinicians, ensuring full study management. Patient-Centric: We prioritize multi-stakeholder co-creation with patient groups and clinical experts, ensuring an inclusive methodology and … Type: | 9 | 2 | 6 | 35 |
 | Hurdle The Complete Diagnostics-as-a-Service Platform 🧬 API-first. Modular. Integrated R&D. Global coverage. Hurdle's mission is clear: democratize access to biology for companies and consumers by creating cutting-edge bio-infrastructure. Harnessing deep expertise, our tech-driven platform integrates easily with any business system. With its modular and end-to-end capabilities, Hurdle ensures biology data is not only accessible but also actionable, breaking down the traditional barriers. We're more than just a platform; we're catalysts for change. Through the profound power of biology, we aim to propel businesses and the world into a brighter, more informed future. Whether your goal is boosting revenue, expanding consumer reach, … Type: | 10 | 0 | 6 | 53 |
Startup